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Available online 19 December 2015Acinetobacter baumannii is an important bacterium that emerged as a signiﬁcant nosocomial pathogen world-
wide. The rise of A. baumannii was due to its multi-drug resistance (MDR), while it was difﬁcult to treat multi-
drug resistant A. baumanniiwith antibiotics, especially in pediatric patients for the therapeutic options with an-
tibiotics were quite limited in pediatric patients. A. baumannii ST208 was identiﬁed as predominant sequence
type of carbapenem resistant A. baumannii in the United States and China. As we knew, there was no complete
genome sequence reproted for A. baumannii ST208, although several whole genome shotgun sequences had
been reported. Here, we sequenced the 4087-kilobase (kb) chromosome and 112-kb plasmid of A. baumannii
XH386 (ST208), which was isolated from a pediatric hospital in China. The genome of A. baumannii XH386
contained 3968 protein-coding genes and 94 RNA-only encoding genes. Genomic analysis and Minimum inhib-
itory concentration assay showed that A. baumannii XH386wasmulti-drug resistant strain, which showed resis-
tance to most of antibiotics, except for tigecycline. The data may be accessed via the GenBank accession number
CP010779 and CP010780.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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. This is an open access article under2. Experimental design, materials and methods
2.1. Introduction
Acinetobacter baumannii is an important bacterium which emerged
as a signiﬁcant nosocomial pathogen worldwide [1]. It caused blood-
stream infection, pneumonia, endocarditis and so on [2]. The rise of
A. baumanniiwas due to its multi-drug resistance, while it was difﬁcult
to treat multi-drug resistant A. baumannii with antibiotics [3,4]. It
caused by A. baumannii had a strong potential to develop antimicrobial
resistance, which largely related to mobile genetic elements [5].
Carbapenme resistance in A. baumannii was mediated most by
oxacillinases (OXAs) and less by metallo-β-lactamases (MBLs) [6]. Car-
bapenem resistance in A. baumanniiwas increasingworldwide, andwas
considered as amarker of emerging antibiotic resistance [7]. CRAB infec-
tion was also a growing problem in the pediatric population. The chil-
dren were susceptible to infections while the therapeutic options with
antibiotics were quite limited. However, the research focusing treat-
ment options on CRAB infections in childrenwas limited. The physicians
were forced to use the data extrapolated from the adult literature [8].the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Cellular and colonial morphology of A. baumannii XH386 Gram stained (A) (1000×) and grown on LB agar (B).
270 Y. Fang et al. / Genomics Data 7 (2016) 269–274For CRAB, sequence types (STs) belonging to the clonal complex 92
(CC92) and the pan-European clonal lineage II (EUII)were predominant
in the United States. Of them, A. baumannii ST208 was one of the twoFig. 2. (A) Phylogenetic tree of Acinetobacter spp. 16S rRNA gene sequences were derived
fromNCBI GenBank. The treewas generatedwithMEGA6.0 using Neighbor-Joiningmeth-
od with 500 bootstraps and standard settings.most common STs of carbapenem-non-susceptible isolates [9]. Recent-
ly, ST 208 had been identiﬁed as predominant ST of Carbapenem Resis-
tant A. baumannii (CRAB) in China [10,11]. These high prevalence of
ST208 carrying blaOXA-23 indicated that ST 208 was an emerging lineage
mediating the spread of carbapenem resistance via blaOXA-23 [10].
The mobility of the resistance genes was mainly mediated by inser-
tions sequences and transposons. The complete genome would be very
useful to study the horizontal transferred resistance genes. Most of
A. baumannii strains that harbored complete genome were isolated
from adult patients. A. baumannii strain XH386 reported in the paper
was isolated from a pediatric patient. This would be helpful to under-
standwhether therewas difference betweenA. baumannii strains isolat-
ed from adult patient and pediatric patient. As we knew, there was no
complete genome sequence of ST208, although several whole genome
shotgun sequences had been reported [12]. Here, we present the com-
plete genome sequence of A. baumannii XH386 (ST208), whichwas iso-
lated from a pediatric hospital in China, together with a summary
classiﬁcation and a set of features.3. Organism information
3.1. Classiﬁcation and features
A. baumannii XH386 is a non-fermentative, strictly aerobic, non-
motile, non-pigmented, catalase-positive and oxidase-negative Gram-
negative coccobacilli (Fig. 1). The strain grew on simple microbiological
media optimally at ~37 °C, forming smooth colonies of ~2mmdiameter.
To evaluate the phylogenomic relationships between A. baumannii
XH386 and other strain in this genus, Phylogenetic tree was generated
with MEGA 6.0 using neighbor-joining method with 500 bootstraps
and standard settings. 16S rRNA gene sequences of Acinetobacter spp.
were derived from NCBI GenBank. The phylogenetic neighborhood of
A. baumannii XH386 in a 16S rDNA gene sequence based tree was
showed in Fig. 2.
To evaluate the phylogenomic relationships between A. baumannii
XH386 and other strains in this species A. baumannii, comparisons be-
tween all the strains were calculated as percentages of similarity using
Gegennes (version 2.2.1). Then, the percentage of similarity was usedTable 1
Summary of genome: one chromosome and one plasmid.
Label Size (Mb) Topology INSDC identiﬁer RefSeq ID
Chromosome 1 4.08 Circular PRJNA273343 CP010779.1
Plasmid 1 0.11 Circular PRJNA273343 CP010780.1
Fig. 3.Graphicalmapof the chromosome (A) and theplasmidpAB386 (B) ofA. baumanniiXH386. Fromoutside to the centre: Genes on forward strand, genes on reverse strand, GC content
(Black), GC skew (purple/olive).
Table 3
Number of genes associated with the 25 general COG functional categories.
Code Value
% of
totala
Description
J 235 5.79 Translation
A 1 0.02 RNA processing and modiﬁcation
K 269 6.62 Transcription
L 131 3.23 Replication, recombination and repair
271Y. Fang et al. / Genomics Data 7 (2016) 269–274to generate a phylogenomic tree with SplitsTree (version 4.13.1). The
phylogenomic relationship in A. baumanniiwas shown in Fig 4A.
4. Genome sequencing information
4.1. Genome project history
The genome was selected based on the isolation site of the strain
XH386. A. baumanniiXH386was amulti-drug resistant bacteria isolated
from a female patient, 10Y3M, with acute bronchopneumonia in a pedi-
atric hospital inHangzhu, China onMay29, 2014. The genome sequence
was completed on 25 Jan., 2015. Annotationwas performed by theNCBI
Prokaryotic Genome Automatic Annotation Pipeline (PGAAP).
4.2. Growth conditions and genomic DNA preparation
A. baumannii XH386was cultured tomid logarithmic phase in 50ml
of LBmedium at 37 °C. DNA for sequencingwas extracted via a QIAamp
DNA minikit (Qiagen Valencia, CA) followed the protocol of the manu-
facturer. The quality of DNA was determined by gel electrophoresisTable 2
Nucleotide content and gene count levels of the genome.
Attribute Genome (total)
Value % of totala
Genome size (bp) 4,087,343 100
DNA coding (bp) 3,627,022 88.7
DNA G + C (bp) 1,596,791 39.1
DNA scaffolds 1 100
Total genes 4062 100
Protein coding genes 3968 97.7
RNA genes 94 2.3
Pseudo genes 26 0.6
Genes in internal clusters Not determined Not determined
Genes with function prediction 3887 95.7
Genes assigned to COGs 3039 74.9
Genes assigned Pfam domains 3268 80.4
Genes with signal peptides 322 21.3
Genes with transmembrane helices 864 2.3
CRISPR repeats 2
a The total is based on either the size of the genome in base pairs or the total number of
protein coding genes in the annotated genome. Also includes 26 pseudogenes and 6
frameshifted genes.andNanoDrop 2000 spectrophotometer (Nano-drop Technologies,Wil-
mington, DE).4.3. Genome sequencing and assembly
The genome of A. baumanniiXH386was sequenced atMeiji Biotech-
nology Company (Shanghai, China) using a hybrid of the Illumina and
Paciﬁc Biosciences (PacBio) technologies. An Illumina standard shotgun
library was constructed, and then was sequenced using the Illumina
HiSeq 2000 platform. 3,798,266 reads totaling 953 Mb were generatedB 0 0.00 Chromatin structure and dynamics
D 39 0.96 Cell cycle control, mitosis and meiosis
Y 0 0.00 Nuclear structure
V 66 1.62 Defense mechanisms
T 117 2.88 Signal transduction mechanisms
M 186 4.58 Cell wall/membrane biogenesis
N 55 1.35 Cell motility
Z 0 0.00 Cytoskeleton
W 3 0.07 Extracellular structures
U 55 1.35 Intracellular trafﬁcking and secretion
O 121 2.98
Posttranslational modiﬁcation, protein turnover,
chaperones
C 201 4.95 Energy production and conversion
G 153 3.77 Carbohydrate transport and metabolism
E 263 6.47 Amino acid transport and metabolism
F 82 2.02 Nucleotide transport and metabolism
H 143 3.52 Coenzyme transport and metabolism
I 221 5.44 Lipid transport and metabolism
P 183 4.51 Inorganic ion transport and metabolism
Q 67 1.65
Secondary metabolites biosynthesis, transport and
catabolism
R 238 5.86 General function prediction only
S 210 5.17 Function unknown
- 1023 25.18 Not in COGs
a The total is based on the total number of protein coding genes in the annotated
genome.
Fig. 4. (A) Phylogenetic tree of phylogenetic tree displaying the relationship between A. baumannii and selected strains of the same species. Comparisons between the strains were calcu-
lated as percentages of similarity using Gegennes. Then, the percentage of similarity was used to generate a phylogenomic treewith SplitsTree andMEGA. The centre of the ﬁgure showed
the MLST of these A. baumannii strains. The left of the ﬁgures showed the abundance of the resistance genes among these A. baumannii strains. The resistance genes were detected by
ResFinder (https://cge.cbs.dtu.dk/services/ResFinder/), and the heat map of the resistance genes was plotted by the R package “ggplot2”. (B) The abundance of the resistance genes
among plasmids of these A. baumannii strains. The resistance genes were detected by ResFinder (https://cge.cbs.dtu.dk/services/ResFinder/), and the heat map of the resistance genes
was plotted by the R package “ggplot2”.
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ed and sequenced on the PacBio RS platform. 150,292 raw PacBio reads
yielded 76,398 adapter trimmed and quality ﬁltered subreads totalling
355 Mb. De novo assembly of the read sequences was performed using
continuous long reads following the Hierarchical Genome Assembly
Process (HGAP) workﬂow (PacBio DevNet; Paciﬁc Biosciences) as avail-
able in SMRT Analysis v2.3.0, and then Breseq v0.25b with Illumina
short reads. The ﬁnal assembly is based on 953Mb of Illumina standard
PE and 355 Mb of PacBio post ﬁltered data, which provides an average
232× Illumina coverage and 54.76× PacBio coverage of the genome, re-
spectively (Table 1).
4.4. Genome annotation
Annotation of A. baumannii XH386 was ﬁnished using the NCBI
PGAAP annotation pipeline and manually checked. The pipeline usesGenemark to predict open reading frames (ORF) and searches against
Proteins Clusters. Protein coding genes were searched against the
NCBI RefSeq database using BLASTp. COG functional categories assign-
ment of the ORFs were archived by BLAST against the COG database.
InterPro searches were also done to identify conserved domains in
each ORF.5. Genome properties
The genome of A. baumannii XH386 is 4,199,500 nucleotides 39.1%
GC content and contain one 4,087,343 bp circular chromosome and
one 112,157 bp circular plasmid (Fig. 3). Among of the 4062 genes, pre-
dicted 3968 were protein-coding genes, and 94 RNAs; 26 pseudogenes
were also identiﬁed. The genome summary and distribution of genes
into COG functional categories are listed in Tables 2 and 3.
Table 4
Antibiotic resistance proﬁles of A. baumannii XH386.
Antibiotic class Resistance
gene
Predicted phenotype Accession
number
Aminoglycoside aph(3′)-Ic Aminoglycoside resistance X62115
aacA4 M60321
aadA1 Aminoglycoside resistance JQ414041
armA Aminoglycoside resistance AY220558
aph(3′)-Ic Aminoglycoside resistance X62115
strA Aminoglycoside resistance M96392
strB Aminoglycoside resistance M96392
Beta-lactam blaADC-25 Beta-lactam resistance EF016355
blaOXA-66 Beta-lactam resistance FJ360530
blaTEM-1D
Beta-lactam resistance AF188200
blaOXA-23 Beta-lactam resistance HQ700358
Fluoroquinolone aac(6′)Ib-cr Fluoroquinolone and
aminoglycoside resistance
EF636461
MLS —macrolide,
lincosamide and
streptogramin B
msr(E) Macrolide, Lincosamide and
Streptogramin B resistance
EU294228
mph(E) Macrolide resistance EU294228
Phenicol catB8 Phenicol resistance AF227506
Sulphonamide sul1 Sulphonamide resistance CP002151
sul2 Sulphonamide resistance GQ421466
Tetracycline tet(B) Tetracycline resistance AP000342
Table 5
The susceptibility proﬁle of A. baumannii XH386.
Antimicrobial drug MIC (mg/L)
Tobramycin N= 128
Gentamicin N= 16
Levoﬂoxacin N= 8
Ciproﬂoxacin N= 4
Cefoperazone-sulbactam 14
Amoxicillin-clavulanic acid N= 32
Piperacillin-tazobactam N= 16
Ampicillin N= 32
Ceftriaxone N= 64
Cefepime N= 64
Cefoxitin N= 64
Imipenem N= 16
Aztreonam N= 64
Cefazolin N= 64
Nitrofurantoin N= 512
Sulfamethoxazole-trimethoprim N= 320
Tigecycline 2
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XH386 and other strains in this species were detected by ResFinder
(https://cge.cbs.dtu.dk/services/ResFinder/). The phylogenetic tree,
MLST and resistance genes of A. baumannii strains was combined
showed in Fig. 4A. The distribution of antibiotic resistance genes in
A. baumannii XH386 was also shown in Table 4. Fig. 4B showed the dis-
tribution of resistance genes in the plasmids harbored by the
A. baumannii strains. The difference of the distribution of antibiotic re-
sistance genes between chromosome and plasmid demonstrate that
the antibiotic resistance genes more often appeared in chromosome.
A. baumannii XH386 was showed resistance to all antibiotics tested ex-
cept tigcycline, namely tobramycin, gentamicin, levoﬂoxacin, ciproﬂox-
acin, cefoperazone-sulbactam, amoxicillin–clavulanic acid, piperacillin–
tazobactam, ampicillin, ceftriaxone, cefepime, cefoxitin, imipenem, az-
treonam, cefazolin, nitrofurantoin, sulfamethoxazole–trimethoprim
(Table 5).
6. Insights from the genome sequence
The detection of blaOXA-23 explained the resistance to carbapenem.
The existence of aac(6)lb-cr, aacA4, aadA1, aph(3)-lc and armA showed
good correlation to the resistance of tobramycin and gentamicin.
A. baumanniiXH386demonstratedmore resistance genes than sensitive
strains, but not the other resistance ST strains, that indicated the emer-
gence of ST208 had affected by other factors, e.g. show high ﬁtness in
clinical environment, more virulence.
7. Conclusions
A. baumannii ST208 was identiﬁed predominant ST of Carbapenem
Resistant A. baumannii in the United States and China. Although several
whole genome shotgun sequences of A. baumannii ST208 had been re-
ported, there was not complete genome sequence of ST208 so far. In
current study, a complete genome of A. baumannii ST208 was reported.
And the genomic analysis showed that multiple antibiotic resistance
geneswere detected in the genome, including resistance to aminoglyco-
side, beta-lactam, ﬂuorequinolone, macrolide, sulphonamide and tetra-
cycline. The genome sequence of A. baumannii XH386 would provide
deeper insight into the molecular resistance mechanisms and it might
facilitate the development of clinical research to control the antibiotic
resistance in A. baumannii.Nucleotide sequence accession number
This complete genome sequence of A. baumannii XH386 has been
deposited at DDBJ/EMBL/GenBank under the accession number
CP010779 and CP010780.
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